$STGW
Stagwell Inc

2021 Q1 Form 10-Q Financial Statement

#000087688321000030 Filed on May 10, 2021

View on sec.gov

Income Statement

Concept 2021 Q1 2020 Q1
Revenue $181.2M $327.7M
YoY Change -44.7% -0.32%
Cost Of Revenue $112.0M $222.7M
YoY Change -49.71% -6.1%
Gross Profit $69.24M $105.0M
YoY Change -34.08% 14.63%
Gross Profit Margin 38.2% 32.05%
Selling, General & Admin $83.95M $66.40M
YoY Change 26.42% -1.04%
% of Gross Profit 121.23% 63.21%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $10.95M $9.206M
YoY Change 18.94% 4.16%
% of Gross Profit 15.81% 8.76%
Operating Expenses $92.12M $75.50M
YoY Change 22.02% -0.53%
Operating Profit $6.015M $29.33M
YoY Change -79.49% 87.01%
Interest Expense -$16.99M -$30.40M
YoY Change -44.13% 169.03%
% of Operating Profit -282.38% -103.66%
Other Income/Expense, Net -$743.0K -$14.03M
YoY Change -94.71% -4.54%
Pretax Income $5.272M $15.29M
YoY Change -65.53% -117.25%
Income Tax $673.0K $13.50M
% Of Pretax Income 12.77% 88.28%
Net Earnings $4.365M $1.002M
YoY Change 335.63% -986.73%
Net Earnings / Revenue 2.41% 0.31%
Basic Earnings Per Share -$0.03
Diluted Earnings Per Share $66.41K -$0.03
COMMON SHARES
Basic Shares Outstanding 73.39M shares 72.40B shares
Diluted Shares Outstanding 75.44M shares 72.40B shares

Balance Sheet

Concept 2021 Q1 2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $113.3M $221.1M
YoY Change -48.74% 737.5%
Cash & Equivalents $113.3M $221.1M
Short-Term Investments
Other Short-Term Assets $31.69M $44.69M
YoY Change -29.09% 0.0%
Inventory
Prepaid Expenses
Receivables $377.7M $406.2M
Other Receivables $0.00 $0.00
Total Short-Term Assets $545.5M $694.8M
YoY Change -21.48% 22.26%
LONG-TERM ASSETS
Property, Plant & Equipment $85.09M $75.77M
YoY Change 12.3% -11.34%
Goodwill $669.1M $716.4M
YoY Change -6.61% -3.55%
Intangibles $30.78M $50.64M
YoY Change -39.21% -21.92%
Long-Term Investments
YoY Change
Other Assets $22.85M $29.62M
YoY Change -22.88% 13.37%
Total Long-Term Assets $1.015B $1.165B
YoY Change -12.85% -7.9%
TOTAL ASSETS
Total Short-Term Assets $545.5M $694.8M
Total Long-Term Assets $1.015B $1.165B
Total Assets $1.561B $1.860B
YoY Change -16.08% 1.45%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $209.7M $153.5M
YoY Change 36.61% -28.51%
Accrued Expenses $186.8M $373.8M
YoY Change -50.02% 26.54%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $715.9M $720.5M
YoY Change -0.64% -1.17%
LONG-TERM LIABILITIES
Long-Term Debt $864.9M $1.014B
YoY Change -14.73% 10.36%
Other Long-Term Liabilities $77.59M $35.52M
YoY Change 118.41% 102.72%
Total Long-Term Liabilities $942.4M $1.050B
YoY Change -10.23% 12.09%
TOTAL LIABILITIES
Total Short-Term Liabilities $715.9M $720.5M
Total Long-Term Liabilities $942.4M $1.050B
Total Liabilities $1.941B $2.008B
YoY Change -3.34% 2.48%
SHAREHOLDERS EQUITY
Retained Earnings -$704.7M -$479.7M
YoY Change 46.91% 3.16%
Common Stock $106.2M $99.59M
YoY Change 6.63% 0.91%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$445.6M -$223.7M
YoY Change
Total Liabilities & Shareholders Equity $1.561B $1.860B
YoY Change -16.08% 1.45%

Cashflow Statement

Concept 2021 Q1 2020 Q1
OPERATING ACTIVITIES
Net Income $4.365M $1.002M
YoY Change 335.63% -986.73%
Depreciation, Depletion And Amortization $10.95M $9.206M
YoY Change 18.94% 4.16%
Cash From Operating Activities $5.771M -$19.96M
YoY Change -128.92% -75.42%
INVESTING ACTIVITIES
Capital Expenditures $3.311M $1.546M
YoY Change 114.17% -57.13%
Acquisitions $0.00 $729.0K
YoY Change -100.0% -30.57%
Other Investing Activities $0.00 $0.00
YoY Change -100.0%
Cash From Investing Activities -$3.311M $16.65M
YoY Change -119.89% -8.04%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00
YoY Change
Debt Paid & Issued, Net $4.608M
YoY Change 200.0%
Cash From Financing Activities -$41.14M $119.6M
YoY Change -134.39% 96.93%
NET CHANGE
Cash From Operating Activities $5.771M -$19.96M
Cash From Investing Activities -$3.311M $16.65M
Cash From Financing Activities -$41.14M $119.6M
Net Change In Cash -$38.67M $114.2M
YoY Change -133.87% -4007.22%
FREE CASH FLOW
Cash From Operating Activities $5.771M -$19.96M
Capital Expenditures $3.311M $1.546M
Free Cash Flow $2.460M -$21.50M
YoY Change -111.44% -74.65%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q1 dei Entity Central Index Key
EntityCentralIndexKey
0000876883
CY2021Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2021Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
CY2021Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2021Q1 dei Amendment Flag
AmendmentFlag
false
CY2021Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
4498000 USD
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
5473000 USD
CY2021Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
137729000 USD
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
136166000 USD
CY2021Q1 dei Document Type
DocumentType
10-Q
CY2021Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
145000000 shares
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
145000000 shares
CY2021Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
145000000 shares
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
145000000 shares
CY2021Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
145000000 shares
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
145000000 shares
CY2021Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2021Q1 dei Document Period End Date
DocumentPeriodEndDate
2021-03-31
CY2021Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2021Q1 dei Entity File Number
EntityFileNumber
001-13718
CY2021Q1 dei Entity Registrant Name
EntityRegistrantName
MDC Partners Inc
CY2021Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
Z4
CY2021Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
98-0364441
CY2021Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
One World Trade Center, Floor 65
CY2021Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
New York,
CY2021Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
CY2021Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10007
CY2021Q1 dei City Area Code
CityAreaCode
646
CY2021Q1 dei Local Phone Number
LocalPhoneNumber
429-1800
CY2021Q1 dei Security12b Title
Security12bTitle
Class A Subordinate Voting Shares, no par value
CY2021Q1 dei Trading Symbol
TradingSymbol
MDCA
CY2021Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2021Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2021Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2021Q1 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2021Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2021Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2021Q1 dei Entity Shell Company
EntityShellCompany
false
CY2021Q1 us-gaap Revenues
Revenues
307585000 USD
CY2020Q1 us-gaap Revenues
Revenues
327742000 USD
CY2021Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
186921000 USD
CY2020Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
222694000 USD
CY2021Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
83946000 USD
CY2020Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
66354000 USD
CY2021Q1 us-gaap Depreciation
Depreciation
8176000 USD
CY2020Q1 us-gaap Depreciation
Depreciation
9206000 USD
CY2021Q1 us-gaap Asset Impairment Charges
AssetImpairmentCharges
875000 USD
CY2020Q1 us-gaap Asset Impairment Charges
AssetImpairmentCharges
161000 USD
CY2021Q1 us-gaap Costs And Expenses
CostsAndExpenses
279918000 USD
CY2020Q1 us-gaap Costs And Expenses
CostsAndExpenses
298415000 USD
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
27667000 USD
CY2020Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
29327000 USD
CY2021Q1 us-gaap Interest And Debt Expense
InterestAndDebtExpense
19065000 USD
CY2020Q1 us-gaap Interest And Debt Expense
InterestAndDebtExpense
15611000 USD
CY2021Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
2080000 USD
CY2020Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-14757000 USD
CY2021Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
614000 USD
CY2020Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
16334000 USD
CY2021Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-16371000 USD
CY2020Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-14034000 USD
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1302000 USD
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
11296000 USD
CY2020Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
15293000 USD
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
13500000 USD
CY2021Q1 mdca Income Loss From Continuing Operations Before Equity In Earnings Of Nonconsolidated Affiliates
IncomeLossFromContinuingOperationsBeforeEquityInEarningsOfNonconsolidatedAffiliates
9994000 USD
CY2020Q1 mdca Income Loss From Continuing Operations Before Equity In Earnings Of Nonconsolidated Affiliates
IncomeLossFromContinuingOperationsBeforeEquityInEarningsOfNonconsolidatedAffiliates
1793000 USD
CY2021Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-493000 USD
CY2020Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
0 USD
CY2021Q1 us-gaap Profit Loss
ProfitLoss
9501000 USD
CY2020Q1 us-gaap Profit Loss
ProfitLoss
1793000 USD
CY2021Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
4491000 USD
CY2020Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
791000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
5010000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
1002000 USD
CY2021Q1 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
921000 USD
CY2020Q1 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-2438000 USD
CY2021Q1 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.01
CY2020Q1 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.03
CY2021Q1 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.01
CY2020Q1 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.03
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
73392824 shares
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
72397661000 shares
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
75439066 shares
CY2020Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
72397661000 shares
CY2021Q1 us-gaap Profit Loss
ProfitLoss
9501000 USD
CY2020Q1 us-gaap Profit Loss
ProfitLoss
1793000 USD
CY2021Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-3507000 USD
CY2020Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
7429000 USD
CY2021Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-3507000 USD
CY2020Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
7429000 USD
CY2021Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
5994000 USD
CY2020Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
9222000 USD
CY2021Q1 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
3539000 USD
CY2020Q1 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
282000 USD
CY2021Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
2455000 USD
CY2020Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
8940000 USD
CY2021Q1 dei Document Period End Date
DocumentPeriodEndDate
2021-03-31
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
113340000 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
60757000 USD
CY2021Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
377670000 USD
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
374892000 USD
CY2021Q1 mdca Expenditures Billable Current
ExpendituresBillableCurrent
22824000 USD
CY2020Q4 mdca Expenditures Billable Current
ExpendituresBillableCurrent
10552000 USD
CY2021Q1 us-gaap Other Assets Current
OtherAssetsCurrent
31687000 USD
CY2020Q4 us-gaap Other Assets Current
OtherAssetsCurrent
40938000 USD
CY2021Q1 us-gaap Assets Current
AssetsCurrent
545521000 USD
CY2020Q4 us-gaap Assets Current
AssetsCurrent
487139000 USD
CY2021Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
85085000 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
90413000 USD
CY2021Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
207418000 USD
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
214188000 USD
CY2021Q1 us-gaap Goodwill
Goodwill
669060000 USD
CY2020Q4 us-gaap Goodwill
Goodwill
668211000 USD
CY2021Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
30784000 USD
CY2020Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
33844000 USD
CY2021Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
22845000 USD
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
17517000 USD
CY2021Q1 us-gaap Assets
Assets
1560713000 USD
CY2020Q4 us-gaap Assets
Assets
1511312000 USD
CY2021Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
209679000 USD
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
168396000 USD
CY2021Q1 mdca Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
242667000 USD
CY2020Q4 mdca Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
274968000 USD
CY2021Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
41229000 USD
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
41208000 USD
CY2021Q1 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
52156000 USD
CY2020Q4 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
53730000 USD
CY2021Q1 us-gaap Liabilities Current
LiabilitiesCurrent
715890000 USD
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
691258000 USD
CY2021Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
864850000 USD
CY2020Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
843184000 USD
CY2021Q1 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
41244000 USD
CY2020Q4 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
29335000 USD
CY2021Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
241375000 USD
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
247243000 USD
CY2021Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
77585000 USD
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
82065000 USD
CY2021Q1 us-gaap Liabilities
Liabilities
1940944000 USD
CY2020Q4 us-gaap Liabilities
Liabilities
1893085000 USD
CY2021Q1 us-gaap Redeemable Noncontrolling Interest Equity Fair Value
RedeemableNoncontrollingInterestEquityFairValue
25352000 USD
CY2020Q4 us-gaap Redeemable Noncontrolling Interest Equity Fair Value
RedeemableNoncontrollingInterestEquityFairValue
27137000 USD
CY2021Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2021Q1 us-gaap Preferred Stock Value
PreferredStockValue
152746000 USD
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
152746000 USD
CY2021Q1 us-gaap Common Stock Value
CommonStockValue
106193000 USD
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
104367000 USD
CY2021Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-704741000 USD
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-709751000 USD
CY2021Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
183000 USD
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
2739000 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-445619000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-449899000 USD
CY2021Q1 us-gaap Minority Interest
MinorityInterest
40036000 USD
CY2020Q4 us-gaap Minority Interest
MinorityInterest
40989000 USD
CY2021Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-405583000 USD
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-408910000 USD
CY2021Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1560713000 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1511312000 USD
CY2021Q1 us-gaap Profit Loss
ProfitLoss
9501000 USD
CY2020Q1 us-gaap Profit Loss
ProfitLoss
1793000 USD
CY2021Q1 us-gaap Share Based Compensation
ShareBasedCompensation
-1963000 USD
CY2020Q1 us-gaap Share Based Compensation
ShareBasedCompensation
3070000 USD
CY2021Q1 us-gaap Depreciation
Depreciation
8176000 USD
CY2020Q1 us-gaap Depreciation
Depreciation
9206000 USD
CY2021Q1 us-gaap Asset Impairment Charges
AssetImpairmentCharges
875000 USD
CY2020Q1 us-gaap Asset Impairment Charges
AssetImpairmentCharges
161000 USD
CY2021Q1 mdca Adjustment To Deferred Acquisition Consideration
AdjustmentToDeferredAcquisitionConsideration
11685000 USD
CY2020Q1 mdca Adjustment To Deferred Acquisition Consideration
AdjustmentToDeferredAcquisitionConsideration
-4600000 USD
CY2021Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
63000 USD
CY2020Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
8511000 USD
CY2021Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2779000 USD
CY2020Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-41148000 USD
CY2021Q1 mdca Increase Decrease In Expenditures Billable To Clients
IncreaseDecreaseInExpendituresBillableToClients
12272000 USD
CY2020Q1 mdca Increase Decrease In Expenditures Billable To Clients
IncreaseDecreaseInExpendituresBillableToClients
-7370000 USD
CY2021Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
7615000 USD
CY2020Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
3385000 USD
CY2021Q1 mdca Increase Decrease In Accounts Payable Accrued Expenses And Other Liabilities
IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities
23977000 USD
CY2020Q1 mdca Increase Decrease In Accounts Payable Accrued Expenses And Other Liabilities
IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities
-62120000 USD
CY2021Q1 us-gaap Payment For Contingent Consideration Liability Operating Activities
PaymentForContingentConsiderationLiabilityOperatingActivities
473000 USD
CY2020Q1 us-gaap Payment For Contingent Consideration Liability Operating Activities
PaymentForContingentConsiderationLiabilityOperatingActivities
782000 USD
CY2021Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
17203000 USD
CY2020Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-24816000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
47060000 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-19955000 USD
CY2021Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
13423000 USD
CY2020Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1546000 USD
CY2021Q1 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
7080000 USD
CY2020Q1 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
18920000 USD
CY2021Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0 USD
CY2020Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
729000 USD
CY2021Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
689000 USD
CY2020Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
0 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-7032000 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
16645000 USD
CY2021Q1 us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
1087000 USD
CY2020Q1 us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
750000 USD
CY2021Q1 us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
5486000 USD
CY2020Q1 us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
4608000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
13427000 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
119642000 USD
CY2021Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-872000 USD
CY2020Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-2164000 USD
CY2021Q1 mdca Cash Cash Equivalents Restricted Cash Restricted Cash Equivalentsand Cash Heldin Trusts Including Cash Classified Within Assets Heldfor Sale Period Increase Decrease
CashCashEquivalentsRestrictedCashRestrictedCashEquivalentsandCashHeldinTrustsIncludingCashClassifiedWithinAssetsHeldforSalePeriodIncreaseDecrease
52583000 USD
CY2020Q1 mdca Cash Cash Equivalents Restricted Cash Restricted Cash Equivalentsand Cash Heldin Trusts Including Cash Classified Within Assets Heldfor Sale Period Increase Decrease
CashCashEquivalentsRestrictedCashRestrictedCashEquivalentsandCashHeldinTrustsIncludingCashClassifiedWithinAssetsHeldforSalePeriodIncreaseDecrease
114168000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
60757000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
106933000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
113340000 USD
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
221101000 USD
CY2021Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
251000 USD
CY2020Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
849000 USD
CY2021Q1 us-gaap Interest Paid Net
InterestPaidNet
317000 USD
CY2020Q1 us-gaap Interest Paid Net
InterestPaidNet
145000 USD
CY2021Q1 dei Document Period End Date
DocumentPeriodEndDate
2021-03-31
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-408910000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
5010000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
5010000 USD
CY2021Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-3507000 USD
CY2021Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0 USD
CY2021Q1 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
202000 USD
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1035000 USD
CY2021Q1 mdca Increase Decreasein Redemption Valueof Redeemable Noncontrolling Interests
IncreaseDecreaseinRedemptionValueofRedeemableNoncontrollingInterests
1681000 USD
CY2021Q1 mdca Adjustmentsto Additional Paidin Capital Changesdueto Business Combinations
AdjustmentstoAdditionalPaidinCapitalChangesduetoBusinessCombinations
-330000 USD
CY2021Q1 us-gaap Stockholders Equity Other
StockholdersEquityOther
360000 USD
CY2021Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-405583000 USD
CY2019Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-190575000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
1002000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
1002000 USD
CY2020Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
7429000 USD
CY2020Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0 USD
CY2020Q1 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
637000 USD
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
476000 USD
CY2020Q1 mdca Increase Decreasein Redemption Valueof Redeemable Noncontrolling Interests
IncreaseDecreaseinRedemptionValueofRedeemableNoncontrollingInterests
-1218000 USD
CY2020Q1 mdca Adjustmentsto Additional Paidin Capital Changesdueto Business Combinations
AdjustmentstoAdditionalPaidinCapitalChangesduetoBusinessCombinations
-503000 USD
CY2020Q1 us-gaap Stockholders Equity Other
StockholdersEquityOther
-82000 USD
CY2020Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-183944000 USD
CY2021Q1 us-gaap Revenues
Revenues
307585000 USD
CY2020Q1 us-gaap Revenues
Revenues
327742000 USD
CY2021Q1 us-gaap Revenues
Revenues
307585000 USD
CY2020Q1 us-gaap Revenues
Revenues
327742000 USD
CY2021Q1 us-gaap Unbilled Contracts Receivable
UnbilledContractsReceivable
59143000 USD
CY2020Q4 us-gaap Unbilled Contracts Receivable
UnbilledContractsReceivable
49110000 USD
CY2021Q1 dei Document Period End Date
DocumentPeriodEndDate
2021-03-31
CY2021Q1 mdca Expenditures Billable Current
ExpendituresBillableCurrent
22824000 USD
CY2020Q4 mdca Expenditures Billable Current
ExpendituresBillableCurrent
10552000 USD
CY2021Q1 dei Document Period End Date
DocumentPeriodEndDate
2021-03-31
CY2021Q1 dei Document Period End Date
DocumentPeriodEndDate
2021-03-31
CY2021Q1 dei Document Period End Date
DocumentPeriodEndDate
2021-03-31
CY2020 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
69699000 USD
CY2021Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2021Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2021Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
5799000 USD
CY2021Q1 dei Document Period End Date
DocumentPeriodEndDate
2021-03-31
CY2021Q1 us-gaap Revenue Remaining Performance Obligation Percentage
RevenueRemainingPerformanceObligationPercentage
0.83
CY2021Q1 us-gaap Revenue Remaining Performance Obligation Percentage
RevenueRemainingPerformanceObligationPercentage
0.17
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
5010000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
1002000 USD
CY2021Q1 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
921000 USD
CY2020Q1 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-2438000 USD
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
73392824 shares
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
72397661000 shares
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
75439066 shares
CY2020Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
72397661000 shares
CY2021Q1 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.01
CY2020Q1 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.03
CY2021Q1 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.01
CY2020Q1 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.03
CY2021Q1 dei Document Period End Date
DocumentPeriodEndDate
2021-03-31
CY2020Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
82802000 USD
CY2019Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
74671000 USD
CY2021Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
-1153000 USD
CY2020 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
-46792000 USD
CY2021Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
12392000 USD
CY2020 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
44993000 USD
CY2021Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Purchases
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases
0 USD
CY2020 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Purchases
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases
7703000 USD
CY2021Q1 mdca Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Foreign Currency Translation Adjustment
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityForeignCurrencyTranslationAdjustment
-641000 USD
CY2020 mdca Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Foreign Currency Translation Adjustment
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityForeignCurrencyTranslationAdjustment
2227000 USD
CY2021Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
93400000 USD
CY2020Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
82802000 USD
CY2021Q1 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
93400000 USD
CY2020Q4 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
83065000 USD
CY2021Q1 mdca Adjustmentstodeferredacquisitionconsiderationincludedinsharebasedcompensation
Adjustmentstodeferredacquisitionconsiderationincludedinsharebasedcompensation
707000 USD
CY2020Q1 mdca Adjustmentstodeferredacquisitionconsiderationincludedinsharebasedcompensation
Adjustmentstodeferredacquisitionconsiderationincludedinsharebasedcompensation
2025000 USD
CY2021Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
12392000 USD
CY2020Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
-2575000 USD
CY2021Q1 dei Document Period End Date
DocumentPeriodEndDate
2021-03-31
CY2021Q1 mdca Lessee Operating Lease Lease Not Yet Commenced Number Of Contracts
LesseeOperatingLeaseLeaseNotYetCommencedNumberOfContracts
5 lease
CY2021Q1 mdca Lessee Operating Lease Lease Not Yet Commenced Number Of Contracts
LesseeOperatingLeaseLeaseNotYetCommencedNumberOfContracts
5 lease
CY2021Q1 dei Document Period End Date
DocumentPeriodEndDate
2021-03-31
CY2021Q1 mdca Lessee Operating Lease Lease Notyet Commenced Liability
LesseeOperatingLeaseLeaseNotyetCommencedLiability
34020000 USD
CY2021Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
17127000 USD
CY2020Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
16391000 USD
CY2021Q1 us-gaap Variable Lease Cost
VariableLeaseCost
2593000 USD
CY2020Q1 us-gaap Variable Lease Cost
VariableLeaseCost
4655000 USD
CY2021Q1 us-gaap Sublease Income
SubleaseIncome
2564000 USD
CY2020Q1 us-gaap Sublease Income
SubleaseIncome
2805000 USD
CY2021Q1 us-gaap Lease Cost
LeaseCost
17156000 USD
CY2020Q1 us-gaap Lease Cost
LeaseCost
18241000 USD
CY2021Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
16796000 USD
CY2020Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
17635000 USD
CY2021Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
3816000 USD
CY2020Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
7119000 USD
CY2021Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P7Y2M12D
CY2020Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P7Y
CY2021Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.106
CY2020Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
8.7
CY2021Q1 mdca Impairment Of Right Of Use Asset And Accelerated Operating Expenses
ImpairmentOfRightOfUseAssetAndAcceleratedOperatingExpenses
875000 USD
CY2020Q1 us-gaap Asset Impairment Charges
AssetImpairmentCharges
161000 USD
CY2021Q1 dei Document Period End Date
DocumentPeriodEndDate
2021-03-31
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
52871000 USD
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
61447000 USD
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
56839000 USD
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
50615000 USD
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
39582000 USD
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
152702000 USD
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
414056000 USD
CY2021Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
131452000 USD
CY2021Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
282604000 USD
CY2021Q1 dei Document Period End Date
DocumentPeriodEndDate
2021-03-31
CY2021Q1 dei Document Period End Date
DocumentPeriodEndDate
2021-03-31
CY2021Q1 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
20000000 USD
CY2020Q4 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
0 USD
CY2021Q1 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
25406000 USD
CY2020Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
27072000 USD
CY2021Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
864850000 USD
CY2020Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
843184000 USD
CY2021Q1 dei Document Period End Date
DocumentPeriodEndDate
2021-03-31
CY2021Q1 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
20000000 USD
CY2021Q1 dei Document Period End Date
DocumentPeriodEndDate
2021-03-31
CY2021Q1 dei Document Period End Date
DocumentPeriodEndDate
2021-03-31
CY2021Q1 dei Document Period End Date
DocumentPeriodEndDate
2021-03-31
CY2019Q4 mdca Accrued And Other Liabilities Attributable To Noncontrolling Interest
AccruedAndOtherLiabilitiesAttributableToNoncontrollingInterest
14028000 USD
CY2020Q1 mdca Accrued Net Income Loss Attributable To Noncontrolling Interest
AccruedNetIncomeLossAttributableToNoncontrollingInterest
21774000 USD
CY2020Q1 mdca Accrued And Other Liabilities Attributable To Noncontrolling Interest Distributions Made
AccruedAndOtherLiabilitiesAttributableToNoncontrollingInterestDistributionsMade
15192000 USD
CY2020Q1 mdca Adjustments To Noncontrolling Interest
AdjustmentsToNoncontrollingInterest
94000 USD
CY2020Q4 mdca Accrued And Other Liabilities Attributable To Noncontrolling Interest
AccruedAndOtherLiabilitiesAttributableToNoncontrollingInterest
20704000 USD
CY2021Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
4491000 USD
CY2021Q1 mdca Accrued And Other Liabilities Attributable To Noncontrolling Interest Distributions Made
AccruedAndOtherLiabilitiesAttributableToNoncontrollingInterestDistributionsMade
5285000 USD
CY2021Q1 mdca Adjustments To Noncontrolling Interest
AdjustmentsToNoncontrollingInterest
36000 USD
CY2021Q1 mdca Accrued And Other Liabilities Attributable To Noncontrolling Interest
AccruedAndOtherLiabilitiesAttributableToNoncontrollingInterest
19946000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
5010000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
1002000 USD
CY2021Q1 mdca Net Income Loss Including Transferfrom Non Controlling Interests
NetIncomeLossIncludingTransferfromNonControllingInterests
4680000 USD
CY2020Q1 mdca Net Income Loss Including Transferfrom Non Controlling Interests
NetIncomeLossIncludingTransferfromNonControllingInterests
499000 USD
CY2020Q4 us-gaap Redeemable Noncontrolling Interest Equity Fair Value
RedeemableNoncontrollingInterestEquityFairValue
27137000 USD
CY2019Q4 us-gaap Redeemable Noncontrolling Interest Equity Fair Value
RedeemableNoncontrollingInterestEquityFairValue
36973000 USD
CY2021Q1 mdca Redeemablenoncontrollinginterestredemptionsvalue
Redeemablenoncontrollinginterestredemptionsvalue
0 USD
CY2020 mdca Redeemablenoncontrollinginterestredemptionsvalue
Redeemablenoncontrollinginterestredemptionsvalue
12289000 USD
CY2021Q1 us-gaap Noncontrolling Interest Increase From Business Combination
NoncontrollingInterestIncreaseFromBusinessCombination
0 USD
CY2020 us-gaap Noncontrolling Interest Increase From Business Combination
NoncontrollingInterestIncreaseFromBusinessCombination
0 USD
CY2021Q1 mdca Redeemablenoncontrollinginterestchangesinredemptionvalue
Redeemablenoncontrollinginterestchangesinredemptionvalue
1681000 USD
CY2020 mdca Redeemablenoncontrollinginterestchangesinredemptionvalue
Redeemablenoncontrollinginterestchangesinredemptionvalue
-2800000 USD
CY2021Q1 mdca Redeemable Noncontrolling Interest Currency Adjustments
RedeemableNoncontrollingInterestCurrencyAdjustments
-104000 USD
CY2020 mdca Redeemable Noncontrolling Interest Currency Adjustments
RedeemableNoncontrollingInterestCurrencyAdjustments
-347000 USD
CY2021Q1 us-gaap Redeemable Noncontrolling Interest Equity Fair Value
RedeemableNoncontrollingInterestEquityFairValue
25352000 USD
CY2020Q4 us-gaap Redeemable Noncontrolling Interest Equity Fair Value
RedeemableNoncontrollingInterestEquityFairValue
27137000 USD
CY2021Q1 us-gaap Redeemable Noncontrolling Interest Equity Fair Value
RedeemableNoncontrollingInterestEquityFairValue
25352000 USD
CY2021Q1 dei Document Period End Date
DocumentPeriodEndDate
2021-03-31
CY2021Q1 dei Document Period End Date
DocumentPeriodEndDate
2021-03-31
CY2021Q1 dei Document Period End Date
DocumentPeriodEndDate
2021-03-31
CY2021Q1 dei Document Period End Date
DocumentPeriodEndDate
2021-03-31
CY2021Q1 dei Document Period End Date
DocumentPeriodEndDate
2021-03-31
CY2021Q1 dei Document Period End Date
DocumentPeriodEndDate
2021-03-31
CY2021Q1 dei Document Period End Date
DocumentPeriodEndDate
2021-03-31
CY2021Q1 dei Document Period End Date
DocumentPeriodEndDate
2021-03-31
CY2021Q1 dei Document Period End Date
DocumentPeriodEndDate
2021-03-31
CY2021Q1 dei Document Period End Date
DocumentPeriodEndDate
2021-03-31
CY2021Q1 mdca Impairmentof Right Of Use Asset
ImpairmentofRightOfUseAsset
598000 USD
CY2020Q1 us-gaap Asset Impairment Charges
AssetImpairmentCharges
161000 USD
CY2021Q1 us-gaap Asset Impairment Charges
AssetImpairmentCharges
875000 USD
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1302000 USD
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
11296000 USD
CY2021Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.115
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
13500000 USD
CY2020Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
15293000 USD
CY2020Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.883
CY2021Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.115
CY2020Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.883
CY2021Q1 dei Document Period End Date
DocumentPeriodEndDate
2021-03-31
CY2021Q1 dei Document Period End Date
DocumentPeriodEndDate
2021-03-31
CY2021Q1 dei Document Period End Date
DocumentPeriodEndDate
2021-03-31
CY2021Q1 dei Document Period End Date
DocumentPeriodEndDate
2021-03-31
CY2021Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
3 reportable_segment
CY2021Q1 us-gaap Revenues
Revenues
307585000 USD
CY2020Q1 us-gaap Revenues
Revenues
327742000 USD
CY2021Q1 mdca Adjusted Ebitda
AdjustedEBITDA
51934000 USD
CY2020Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
9206000 USD
CY2021Q1 us-gaap Asset Impairment Charges
AssetImpairmentCharges
875000 USD
CY2020Q1 mdca Adjusted Ebitda
AdjustedEBITDA
39566000 USD
CY2021Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
8176000 USD
CY2020Q1 us-gaap Asset Impairment Charges
AssetImpairmentCharges
161000 USD
CY2021Q1 us-gaap Share Based Compensation
ShareBasedCompensation
-1963000 USD
CY2020Q1 us-gaap Share Based Compensation
ShareBasedCompensation
3070000 USD
CY2021Q1 mdca Deferred Acquisition Consideration Expense Income
DeferredAcquisitionConsiderationExpenseIncome
-11685000 USD
CY2020Q1 mdca Deferred Acquisition Consideration Expense Income
DeferredAcquisitionConsiderationExpenseIncome
4600000 USD
CY2021Q1 us-gaap Proceeds From Payments To Minority Shareholders
ProceedsFromPaymentsToMinorityShareholders
-9000 USD
CY2020Q1 us-gaap Proceeds From Payments To Minority Shareholders
ProceedsFromPaymentsToMinorityShareholders
14000 USD
CY2021Q1 us-gaap Other Operating Income
OtherOperatingIncome
5485000 USD
CY2020Q1 us-gaap Other Operating Income
OtherOperatingIncome
2416000 USD
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
27667000 USD
CY2020Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
29327000 USD
CY2021Q1 us-gaap Interest And Debt Expense
InterestAndDebtExpense
19065000 USD
CY2020Q1 us-gaap Interest And Debt Expense
InterestAndDebtExpense
15611000 USD
CY2021Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
2080000 USD
CY2020Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-14757000 USD
CY2021Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
614000 USD
CY2020Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
16334000 USD
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
11296000 USD
CY2020Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
15293000 USD
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1302000 USD
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
13500000 USD
CY2021Q1 mdca Income Loss From Continuing Operations Before Equity In Earnings Of Nonconsolidated Affiliates
IncomeLossFromContinuingOperationsBeforeEquityInEarningsOfNonconsolidatedAffiliates
9994000 USD
CY2020Q1 mdca Income Loss From Continuing Operations Before Equity In Earnings Of Nonconsolidated Affiliates
IncomeLossFromContinuingOperationsBeforeEquityInEarningsOfNonconsolidatedAffiliates
1793000 USD
CY2021Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-493000 USD
CY2020Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
0 USD
CY2021Q1 us-gaap Profit Loss
ProfitLoss
9501000 USD
CY2020Q1 us-gaap Profit Loss
ProfitLoss
1793000 USD
CY2021Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
4491000 USD
CY2020Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
791000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
5010000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
1002000 USD
CY2021Q1 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
921000 USD
CY2020Q1 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-2438000 USD
CY2021Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
8176000 USD
CY2020Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
9206000 USD
CY2021Q1 us-gaap Share Based Compensation
ShareBasedCompensation
-1963000 USD
CY2020Q1 us-gaap Share Based Compensation
ShareBasedCompensation
3070000 USD
CY2021Q1 mdca Capital Expenditures Incurred Paid And Not Yet Paid
CapitalExpendituresIncurredPaidAndNotYetPaid
516000 USD
CY2020Q1 mdca Capital Expenditures Incurred Paid And Not Yet Paid
CapitalExpendituresIncurredPaidAndNotYetPaid
1546000 USD
CY2021Q1 dei Document Period End Date
DocumentPeriodEndDate
2021-03-31
CY2021Q1 dei Document Period End Date
DocumentPeriodEndDate
2021-03-31
CY2021Q1 dei Document Period End Date
DocumentPeriodEndDate
2021-03-31
CY2021Q1 dei Document Period End Date
DocumentPeriodEndDate
2021-03-31

Files In Submission

Name View Source Status
0000876883-21-000030-index-headers.html Edgar Link pending
0000876883-21-000030-index.html Edgar Link pending
0000876883-21-000030.txt Edgar Link pending
0000876883-21-000030-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
mdca-20210331.htm Edgar Link pending
mdca-20210331.xsd Edgar Link pending
mdca-20210331xex311xmpenn.htm Edgar Link pending
mdca-20210331xex312xflanuto.htm Edgar Link pending
mdca-20210331xex321xmpenn.htm Edgar Link pending
mdca-20210331xex322xflanuto.htm Edgar Link pending
mdca-20210331_cal.xml Edgar Link unprocessable
mdca-20210331_def.xml Edgar Link unprocessable
mdca-20210331_htm.xml Edgar Link completed
mdca-20210331_lab.xml Edgar Link unprocessable
mdca-20210331_pre.xml Edgar Link unprocessable
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending